Cargando…

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration

Age-related macular degeneration (AMD), a retinal degenerative disease, is the leading cause of central vision loss among the elderly population in developed countries and an increasing global burden. The major risk is aging, compounded by other environmental factors and association with genetic var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molins, Blanca, Romero-Vázquez, Sara, Fuentes-Prior, Pablo, Adan, Alfredo, Dick, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916960/ https://www.ncbi.nlm.nih.gov/pubmed/29725335 http://dx.doi.org/10.3389/fimmu.2018.00808

Ejemplares similares

Activation of C-reactive protein proinflammatory phenotype in the blood retinal barrier in vitro: implications for age-related macular degeneration
por: Romero-Vázquez, Sara, et al.
Publicado: (2020)

Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women
por: Fernandez-Robredo, Patricia, et al.
Publicado: (2018)

Interlink between Inflammation and Oxidative Stress in Age-Related Macular Degeneration: Role of Complement Factor H
por: Romero-Vazquez, Sara, et al.
Publicado: (2021)

C-reactive protein isoforms as prognostic markers of COVID-19 severity
por: Molins, Blanca, et al.
Publicado: (2023)

Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants
por: Molins, Blanca, et al.
Publicado: (2016)

Editorial: C-Reactive Protein in Age-Related Disorders
por: Slevin, Mark, et al.
Publicado: (2018)

Editorial: C-Reactive Protein in Age-Related Disorders, Volume II
por: Slevin, Mark, et al.
Publicado: (2022)

C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration
por: Chirco, Kathleen R., et al.
Publicado: (2018)

Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema
por: Matas, Jessica, et al.
Publicado: (2020)

Bruch’s Membrane Compartmentalizes Complement Regulation in the Eye with Implications for Therapeutic Design in Age-Related Macular Degeneration
por: Clark, Simon J., et al.
Publicado: (2017)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
por: Sato, Tomohito, et al.
Publicado: (2021)

Therapeutic Approaches for Age-Related Macular Degeneration
por: Galindo-Camacho, Ruth M., et al.
Publicado: (2022)

Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema
por: Figueras-Roca, Marc, et al.
Publicado: (2017)

Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet's Disease
por: Mesquida, Marina, et al.
Publicado: (2014)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
por: Kauppinen, Anu, et al.
Publicado: (2020)

Smoking and Age-Related Macular Degeneration: Review and Update
por: Velilla, Sara, et al.
Publicado: (2013)

Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target
por: Bellezza, Ilaria
Publicado: (2018)

Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration?
por: Yang, Ming, et al.
Publicado: (2020)

Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
por: Delaunay, Kimberley, et al.
Publicado: (2021)

Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome
por: de Jong, Sarah, et al.
Publicado: (2022)

Zinc-induced Self-association of Complement C3b and Factor H: IMPLICATIONS FOR INFLAMMATION AND AGE-RELATED MACULAR DEGENERATION
por: Nan, Ruodan, et al.
Publicado: (2013)

Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)

CCR3 is a therapeutic and diagnostic target for neovascular age-related macular degeneration
por: Takeda, Atsunobu, et al.
Publicado: (2009)

Autoimmune-Mediated Retinopathy in CXCR5-Deficient Mice as the Result of Age-Related Macular Degeneration Associated Proteins Accumulation
por: Lennikov, Anton, et al.
Publicado: (2019)

The Role of the Immune Response in Age-Related Macular Degeneration
por: Whitcup, Scott M., et al.
Publicado: (2013)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Complement System and Potential Therapeutics in Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2021)

Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential
por: Stradiotto, Elisa, et al.
Publicado: (2022)

Targeting Tissue Lipids in Age-related Macular Degeneration
por: Apte, Rajendra S.
Publicado: (2016)

Targeting MAPK Signaling in Age-Related Macular Degeneration
por: Kyosseva, Svetlana V.
Publicado: (2016)

Causal Effects of Gut Microbiota on Age-Related Macular Degeneration: A Mendelian Randomization Study
por: Mao, Deshen, et al.
Publicado: (2023)

Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration
por: Maurya, Meenakshi, et al.
Publicado: (2023)

Vitamin D and Age-Related Macular Degeneration
por: Garcia Layana, Alfredo, et al.
Publicado: (2017)

Therapeutic Lowering of C-Reactive Protein
por: Jimenez, Rachel V., et al.
Publicado: (2021)

Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration
por: Lee, Keng Siang, et al.
Publicado: (2021)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Therapeutic potential of translocator protein ligands for age-related macular degeneration
por: Li, Xing, et al.
Publicado: (2021)

Extracellular vesicles as a potential therapeutic for age-related macular degeneration
por: Chow, Lorraine L. C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2k52ain5l0rq2cu1eqbdk9vmf